Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
Clinical trial NCT04954014 · TERMINATED
Trial details
- NCT number
- NCT04954014
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2021-08-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.